Halozyme Therapeutics, Inc. (HALO)
67.12
-2.09
(-3.02%)
USD |
NASDAQ |
May 15, 16:00
67.14
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap : 7.961B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 110.90B |
| Agenus, Inc. | 149.08M |
| Inovio Pharmaceuticals, Inc. | 106.96M |
| Curis, Inc. | 19.11M |
| LadRx Corp. | 0.053M |
Market Cap Related Metrics
| PE Ratio | 24.14 |
| PS Ratio | 5.418 |
| Price to Book Value | 36.25 |
| Price to Free Cash Flow | 12.24 |
| Price | 67.12 |
| Earnings Yield | 4.14% |
| Operating PE Ratio | 9.511 |
| Normalized PE Ratio | 13.76 |